LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)

· St George's, University of London

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6), covering 2008-11-03 to 2008-11-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6) [Phase 1]

See pricing